We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Valeant Pharmaceuticals International announced that it has obtained the requisite lender approval for the previously announced amendment of the Company's existing credit agreement...